News

The preliminary results of the Apple Heart Study highlight the potential role that consumer digital...

With four oral JAK-i therapies expected to be available to rheumatoid arthritis patients by the...

The largest clinical oncology conference provided an insight into the future of oncology care from...

The BHBIA’s Annual Conference did not disappoint again this year. The conference topic ‘The Ripple...

MaxDiff, also known as best-worst scaling, is a quantitative tool providing prioritisation of needs, attributes...

Immunology is one of Vox.Bio’s therapeutic areas of expertise and there is a lot happening...

Market research with onocology patients, even those with metastatic or terminal diagnosis is not out...

When budgets are tight and there is a lot of content to cover clients often...

“Conjoint”, especially in the context of healthcare research, can be considered a daunting and scary...

ASCO has endorsed SIO guidelines to encourage clinicians to discuss alternative therapies with patients Many...

For Vox.Bio’s Summer Social event this year we headed out into (a very hot and...

NHS England has become the first EU country to approve a full access deal for...

On October 16th AbbVie’s blockbuster Humira will face competition from at least four biosimilars in...

Vox.Bio celebrated the holiday season with a lunch in London for our UK based team....

Whilst hybrid closed loop systems dominated the sessions and conference narrative at the American Diabetes...

Vox.Bio has just returned from a thought provoking EphMRA conference in Warsaw. A significant number...

The teams at Vox.Bio and Cambridge Healthcare Research, are really passionate about the therapeutic areas...

At Vox.Bio, we believe it is essential for us to keep up to date with...

Following our recent content series on patient influencers (check out the blog series here), we’re...

Vox.Bio has been recognised with the award “Top Medical Device Consulting Company in the UK”...

We’re thrilled to announce that Gaia Ferracci, Senior Research Executive has been announced as one...

Pharmaceutical companies increasingly claim to be ‘patient-centric’ – a ‘tick-box’ buzzword used primarily to improve...

We’re passionate about insights and data, and Vox.Bio we believe that looking beyond your own...

Watch the webinar in full here.   On Tuesday 25th April 2023 we were thrilled...